(firstQuint)A Dose-finding Study of ASP4070.

 Subjects will be vaccinated with ASP4070 or placebo at 2 week intervals.

 Clinical symptoms will be evaluated after cedar pollen exposure in a chamber at 4, 8 and 12 weeks after the last vaccination to identify the timing of the onset of therapeutic effect.

.

 A Dose-finding Study of ASP4070@highlight

The objective of this study is to evaluate the efficacy, safety, and dose-response of ASP4070 vaccinated in patients with cedar pollinosis.

